Novigenix publishes multi-center study of Colox^® in Clinical Cancer Research : Data validate blood-based test’s ability to detect colorectal cancer early and reliably.

Novigenix SA today announced the publication of a clinical validation study of Colox in the highly ranked journal Clinical Cancer Research. Colox is a blood test based on a 29-gene host immune response panel in combination with tumor biomarkers for the early detection of colorectal cancer (CRC).

> Press release Novigenix